CompletedInterventionalNot ApplicableUpdated Jun 23, 2015
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty | NCT02327312 | Trialant
TerminatedInterventionalNot ApplicableUpdated Dec 22, 2022
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
ClinicalTrials.gov ID
NCT02327312
Lead Sponsor
Glaukos CorporationINDUSTRY
Overall Status
Terminated
Study Type
Interventional
Phase
Not Applicable
Enrollment
91Actual
Last Update Posted
Dec 22, 2022Actual
Start Date
Dec 16, 2014Actual
Primary Completion Date
May 31, 2019Actual
Completion Date
Aug 11, 2020Actual
Brief Summary
To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma
Primary Open-Angle Glaucoma
Stents
Laser
Laser Trabeculoplasty
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Open angle Glaucoma
Exclusion Criteria:
Active corneal inflammation or edema
Choroidal detachment, effusion, choroiditis
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
-
Glendale, Arizona 85306, United States
-
Fayetteville, Arkansas 72704, United States
-
Hemet, California 92545, United States
-
Cape Coral, Florida 33904, United States
-
Elizabeth City, North Carolina 27909, United States